FDA Tackles Regulatory Science Challenge With Help From NIH
This article was originally published in The Tan Sheet
Executive Summary
The National Institutes of Health will look at investing more in regulatory science if the academic and nonprofit research community shows strong interest in the $6.75 million research program NIH and FDA are funding
You may also be interested in...
FDA Commissioner Sees Industry Role In Regulatory Science Initiative
Drug and device firms should have a seat at the table as FDA strengthens its regulatory science program and thus speeds pre-market product reviews, Commissioner Margaret Hamburg says
Better FDA-NIH Cooperation Urged To Ease Barriers To Introducing Products
FDA and National Institutes of Health staff should compare notes earlier to ensure research conducted under the NIH umbrella also meets the needs of FDA regulators, according to comments at a public meeting sponsored by the agencies
FDA Commissioner Sees Industry Role In Regulatory Science Initiative
Drug and device firms should have a seat at the table as FDA strengthens its regulatory science program and thus speeds pre-market product reviews, Commissioner Margaret Hamburg says